Clinical trial
Retrospective Observational Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Patients With BMI>25 kg/m^2, in Real World Clinical Setting
NCT03604224 is registered in ClinicalTrials.gov with Johnson & Johnson Private Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Observational Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Patients With BMI>25 kg/m^2, in Real World Clinical Setting
- Lead sponsor
- Johnson & Johnson Private Limited
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 5, 2018
- Completion date
- July 1, 2019
- Enrollment
- 178 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.